Interestingly, in contrast, the YAPC LGALS3 knockout signature did not show significant modulation of LGALS3BP, suggesting that the regulation observed in patient tumors may not be directly mediated by LGALS3 loss, or that additional tumor microenvironmental or systemic factors are required for this regulation. The gene discussed is LGALS3BP; the disease is neoplasm.